The objective was to elucidate the molecular mechanisms through which exercise confers anti-aging effects and mitigates degenerative functional decline by restoring mitochondrial homeostasis.
Abstract
Summary Age-associated organ dysfunction markedly impairs quality of life and increases mortality in older adults. Aging frequently results in compromised mitochondrial function in organs with high energy demands, such as skeletal muscle, the brain, heart, kidneys, and liver. This impairment leads to excessive production of reactive oxygen species, increased inflammation, energy deficits, and aberrant cellular signaling, collectively fostering cellular senescence, and chronic diseases. Empirical research has demonstrated that regular physical exercise preserves mitochondrial integrity. This review summarizes common and specific responses to exercise in mitochondrial regulation across various organs and provides a comprehensive cross-organ analysis. The objective was to elucidate the molecular mechanisms through which exercise confers anti-aging effects and mitigates degenerative functional decline by restoring mitochondrial homeostasis. This review provides a theoretical foundation for developing targeted anti-aging interventions and for attenuating aging in multiple organs through lifestyle modifications.
This review elucidates the molecular mechanisms governing mitochondrial quality control in skeletal muscle and examines the consequences of its failure, and Notably, exercise emerges as a potent, cost-effective intervention to restore mitochondrial homeostasis.
This review proposes that tailored exercise strategies targeting mitophagy may provide a scalable, non‐pharmacological approach to preserve mitochondrial quality and functional resilience during aging.
Peng Ran, Li-Fang Yang· IUBMB Life - A Journal of th...· 0 citations
Emerging technologies, including human muscle atlases and spatial transcriptomics, together with exercise‐based interventions, will help to identify of novel biomarkers and therapeutic targets to better prevent and treat sarcopenia.
J. D. Hernández-Camacho, Marielle Saclier· Journal of Cellular Physiolo...· 0 citations
This review synthesizes current evidence on the molecular mechanisms underlying inflammation-driven sarcopenia and outlines potential therapeutic strategies targeting the inflammatory microenvironment, offering insights for future research and clinical management.
Xuesong Wang, Shannah Erasmus, Zewen Chu et al.· Aging and Disease· 0 citations
The molecular assembly, physiological roles, and longevity implications of SC in healthy mammals, and emerging evidence supporting SC modulation as a potential strategy for promoting healthy aging are discussed.
Shinichiro Suzuki, K. Ikeda, Toshihiko Takeiwa et al.· Frontiers in Aging· 0 citations
Meloxicam (Mcam) is identified as a small molecule inducer of Cdon that enhances myogenic differentiation, increases muscle mass and function in young mice and mitigates age-related muscle atrophy, and is identified as a potential therapeutic target for age-associated skeletal muscle degeneration.
Ju-Hyeon Bae, Hyun-Kyung So, Yideul Jeong et al.· Experimental and Molecular M...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.